Panagora Asset Management Inc Coherus Bio Sciences, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $1.1 Million - $2.49 Million	-188,094 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$10.92 - $16.41 $102,058 - $153,367	9,346 Added 5.23%	188,094 $2.43 Million
Q4 2021 Feb 10, 2022	BUY	$15.81 - $18.99 $2.83 Million - $3.39 Million	178,748 New	178,748 $2.85 Million
Q3 2021 Nov 10, 2021	SELL	$12.68 - $17.79 $1,394 - $1,956	-110 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$12.95 - $15.41 $38,785 - $46,152	-2,995 Reduced 96.46%	110 $2,000
Q2 2020 Aug 12, 2020	SELL	$14.43 - $19.16 $408,037 - $541,787	-28,277 Reduced 90.11%	3,105 $55,000
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $2.45 Million - $4.73 Million	-209,989 Reduced 87.0%	31,382 $509,000
Q4 2019 Feb 12, 2020	BUY	$16.33 - $21.37 $3.49 Million - $4.57 Million	213,757 Added 774.09%	241,371 $4.35 Million
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $450,108 - $645,339	27,614 New	27,614 $559,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.